نتایج جستجو برای: psuedomonas aeruginosa

تعداد نتایج: 32828  

2010
Amy J Scott-Thomas Mona Syhre Philip K Pattemore Michael Epton Richard Laing John Pearson Stephen T Chambers

BACKGROUND Pseudomonas aeruginosa infections are associated with progressive life threatening decline of lung function in cystic fibrosis sufferers. Growth of Ps. aeruginosa releases a "grape-like" odour that has been identified as the microbial volatile organic compound 2-aminoacetophenone (2-AA). METHODS We investigated 2-AA for its specificity to Ps. aeruginosa and its suitability as a pot...

2017
Payel Chatterjee Elizabeth Davis Fengan Yu Sarah James Julia H. Wildschutte Daniel D. Wiegmann David H. Sherman Robert M. McKay John J. LiPuma Hans Wildschutte

Pseudomonas aeruginosa is an opportunistic pathogen which is evolving resistance to many currently used antibiotics. While much research has been devoted to the roles of pathogenic P. aeruginosa in cystic fibrosis (CF) patients, less is known of its ecological properties. P. aeruginosa dominates the lungs during chronic infection in CF patients, yet its abundance in some environments is less th...

2012
Nicola Ivan Lorè Cristina Cigana Ida De Fino Camilla Riva Mario Juhas Stephan Schwager Leo Eberl Alessandra Bragonzi

The opportunistic pathogen Pseudomonas aeruginosa is able to thrive in diverse ecological niches and to cause serious human infection. P. aeruginosa environmental strains are producing various virulence factors that are required for establishing acute infections in several host organisms; however, the P. aeruginosa phenotypic variants favour long-term persistence in the cystic fibrosis (CF) air...

Journal: :Antimicrobial agents and chemotherapy 2007
Thomas P Lodise Christopher D Miller Jeffrey Graves Jon P Furuno Jessina C McGregor Ben Lomaestro Eileen Graffunder Louise-Anne McNutt

Despite the increasing prevalence of multiple-drug-resistant (MDR) Pseudomonas aeruginosa, the factors predictive of MDR have not been extensively explored. We sought to examine factors predictive of MDR among patients with P. aeruginosa respiratory tract infections and to develop a tool to estimate the probability of MDR among such high-risk patients. This was a single-site, case-control study...

Journal: :Applied and environmental microbiology 2012
Weihua Chu Tesfalem R Zere Mary M Weber Thomas K Wood Marvin Whiteley Benjamin Hidalgo-Romano Ernesto Valenzuela Robert J C McLean

Indole production by Escherichia coli, discovered in the early 20th century, has been used as a diagnostic marker for distinguishing E. coli from other enteric bacteria. By using transcriptional profiling and competition studies with defined mutants, we show that cyclic AMP (cAMP)-regulated indole formation is a major factor that enables E. coli growth in mixed biofilm and planktonic population...

2014
Renata Souto Carina M. Silva-Boghossian Ana Paula Vieira Colombo

P. aeruginosa and Acinetobacter spp. are important pathogens associated with late nosocomial pneumonia in hospitalized and institutionalized individuals. The oral cavity may be a major source of these respiratory pathogens, particularly in the presence of poor oral hygiene and periodontal infection. This study investigated the prevalence of P. aeruginosa and Acinetobacter spp. in subgingival bi...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2003
Daniel J Wozniak Timna J O Wyckoff Melissa Starkey Rebecca Keyser Parastoo Azadi George A O'Toole Matthew R Parsek

The bacterium Pseudomonas aeruginosa causes chronic respiratory infections in cystic fibrosis (CF) patients. Such infections are extremely difficult to control because the bacteria exhibit a biofilm-mode of growth, rendering P. aeruginosa resistant to antibiotics and phagocytic cells. During the course of infection, P. aeruginosa usually undergoes a phenotypic switch to a mucoid colony, which i...

2012
Pieter C Goeminne Thomas Vandendriessche Johan Van Eldere Bart M Nicolai Maarten LATM Hertog Lieven J Dupont

INTRODUCTION Chronic pulmonary infection is the hallmark of cystic fibrosis lung disease. Searching for faster and easier screening may lead to faster diagnosis and treatment of Pseudomonas aeruginosa (P. aeruginosa). Our aim was to analyze and build a model to predict the presence of P. aeruginosa in sputa. METHODS Sputa from 28 bronchiectatic patients were used for bacterial culturing and a...

2017
Naoki Hayashi Atsushi Yokotani Masami Yamamoto Mariko Kososhi Mayu Morita Chiaki Fukunishi Nagisa Nishizawa Naomasa Gotoh

Pseudomonas aeruginosa can penetrate the layer of mucus formed by host intestinal epithelial cells, often resulting in sepsis in immunocompromised patients. We have previously demonstrated that P. aeruginosa can penetrate the mucin layer by flagellar motility and the degradation of the mucin layer. However, it remains unclear how P. aeruginosa initially recognizes epithelial cells. Using the hu...

2017
Hongdong Li Xingyuan Li Chao Song Yunhui Zhang Zhengli Wang Zhenqiu Liu Hong Wei Jialin Yu

Bacterial communication systems, such as quorum sensing (QS), have provided new insights of alternative approaches in antimicrobial treatment. We recently reported that one QS signal, named as autoinducer-2 (AI-2), can affect the behaviors of Pseudomonas aeruginosa PAO1 in a dose-dependent manner. In this study, we aimed to investigate the effects of AI-2 on P. aeruginosa PAO1 biofilm formation...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید